Related Experiment Video
Updated: Feb 5, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
Development of and Progression of Overt Heart Failure in Nonobstructive Hypertrophic Cardiomyopathy
Yasmine L Hiemstra1, Philippe Debonnaire2, Erik W van Zwet3
1Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
Insights
Predictors of heart failure (HF) in hypertrophic cardiomyopathy (HC) include age, New York Heart Association class, left ventricular global longitudinal strain (GLS), and left atrial volume (LAVI). These factors, along with their changes over time, are associated with HF development in HC patients.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Heart Failure Research
Background:
- Few studies identify heart failure (HF) predictors in hypertrophic cardiomyopathy (HC).
- Natural progression of left ventricular (LV) abnormalities and HF association in HC are poorly understood.
- Serial echocardiographic data in HC patients are limited.
Purpose of the Study:
- Assess prognostic value of LV global longitudinal strain (GLS) and other factors for HF development in nonobstructive HC.
- Correlate changes in echocardiographic parameters over time with HF development.
- Investigate progression of LV abnormalities in HC.
Main Methods:
- Echocardiography performed in 236 HC patients at baseline and during follow-up (6.5 years).
- Endpoint: new HF development or progression to NYHA class III/IV.
- Linear mixed model analysis for echocardiographic changes; multivariable Cox regression for predictors.
Main Results:
- 40 patients reached the HF endpoint.
- Independent HF predictors: age (HR 1.04), NYHA class (HR 2.30), GLS (HR 1.15), and LAVI (HR 2.22).
- GLS and LAVI remained stable in non-HF patients but changed significantly in those who developed HF (p<0.05).
Conclusions:
- LV dysfunction is progressive in nonobstructive HC, detectable by serial echocardiography.
- Baseline GLS and LAVI, and their longitudinal changes, predict HF development.
- Echocardiographic parameters offer prognostic value for HF in HC.
Abstract:
Only few studies aimed at identifying predictors of heart failure (HF) in hypertrophic cardiomyopathy (HC) patients. Furthermore, serial echocardiographic analyses are lacking in these patients and little is known about the natural progression of left ventricular (LV) abnormalities and their association with HF development. Aim of this study was to assess the prognostic value of LV global longitudinal strain (GLS) and other clinical and echocardiographic characteristics for the development of HF in patients with nonobstructive HC; furthermore, changes in echocardiographic parameters over time were correlated with HF development. Echocardiography was performed in 236 HC patients (68% men, age: 50 ± 14 years) at their initial visit and during follow-up (6.5(4.1 to 9.8) years). The end point of new HF development or progression to New York Heart Association class III/IV was noted and echocardiographic changes over time were compared among patients with and without HF using linear mixed model analysis. In total, 40 patients reached the HF end point. Multivariable cox regression analysis showed that age (HR 1.04(1.01 to 1.06), p = 0.016), New York Heart Association class (HR 2.30(1.07 to 4.95), p = 0.033), GLS (HR 1.15(1.05 to 1.22), p = 0.001), and left atrial volume (LAVI, HR 2.22(1.10 to 4.50), p = 0.027) were independently associated with the HF end point. Echocardiographic parameters, including GLS and LAVI, remained stable over time in patients without HF end point, but changed significantly in patients who developed HF (group-time interaction, p = 0.042 for GLS and p = 0.027 for LAVI). In conclusion, LV dysfunction is a progressive phenomenon in nonobstructive HC patients which can be detected by repeated echocardiography. Importantly, GLS and LAVI at baseline as well as their changes over time are associated with HF.
More Related Videos
07:13A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure
Published on: April 30, 2020
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure VI: Adjunct Therapies
Heart Failure Drugs: Diuretics